Synthesis of Hemoregulatory Peptide(HP) Analogues

博士 === 中國醫藥學院 === 藥物化學研究所 === 88 === In my search for novel inhibitors of methionine S-adenosyl transferase(MAT)and potentiators of the activity of retinoic acid in inducing differentiation of HL-60 cells. A series of HP analogues(HP1~12)were designed. The solid phase peptide synthetic procedure wa...

Full description

Bibliographic Details
Main Authors: Yuan Shan Tu, 涂源善
Other Authors: Sheng Chu Kuo
Format: Others
Language:zh-TW
Published: 2000
Online Access:http://ndltd.ncl.edu.tw/handle/95656064709529778386
id ndltd-TW-088CMCH0549015
record_format oai_dc
spelling ndltd-TW-088CMCH05490152015-10-13T11:50:52Z http://ndltd.ncl.edu.tw/handle/95656064709529778386 Synthesis of Hemoregulatory Peptide(HP) Analogues 合成HP類緣化合物作為MAT之抑制劑以及細胞分化幫助劑 Yuan Shan Tu 涂源善 博士 中國醫藥學院 藥物化學研究所 88 In my search for novel inhibitors of methionine S-adenosyl transferase(MAT)and potentiators of the activity of retinoic acid in inducing differentiation of HL-60 cells. A series of HP analogues(HP1~12)were designed. The solid phase peptide synthetic procedure was adopted for the preparation of these target peptides. Preliminary tests of their inhibitory effects on the MAT of HL-60 cells was performed according to the surface plasmon resonance(SPR)technology. Results indicate that PyroGlu-Glu-Glu-Cys-Lys-OH (HP1) and PyroGlu-Asp-Asp-Cys-Lys-OH(HP3) ,both being natural HP, displayed significant inhibitory effects. The synthetic HP6, obtained by converting the C-terminal-COOH of HP1 to-CONH2, demonstrated improved activity over HP1. After testing the target peptides on HL-60 cells for differentiation and proliferation capability, a preliminary SAR was established. All of the peptides (HP1~12) showed significant activity. Among them, PaA-Glu-Glu-Cys-Lys-NH2 (HP12) exhibited the highest activity with about 50 times the potency of phenylacetic acid in the potentiating activity of retinoic acid to induce cell differentiation. Sheng Chu Kuo 郭盛助 2000 學位論文 ; thesis 56 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 博士 === 中國醫藥學院 === 藥物化學研究所 === 88 === In my search for novel inhibitors of methionine S-adenosyl transferase(MAT)and potentiators of the activity of retinoic acid in inducing differentiation of HL-60 cells. A series of HP analogues(HP1~12)were designed. The solid phase peptide synthetic procedure was adopted for the preparation of these target peptides. Preliminary tests of their inhibitory effects on the MAT of HL-60 cells was performed according to the surface plasmon resonance(SPR)technology. Results indicate that PyroGlu-Glu-Glu-Cys-Lys-OH (HP1) and PyroGlu-Asp-Asp-Cys-Lys-OH(HP3) ,both being natural HP, displayed significant inhibitory effects. The synthetic HP6, obtained by converting the C-terminal-COOH of HP1 to-CONH2, demonstrated improved activity over HP1. After testing the target peptides on HL-60 cells for differentiation and proliferation capability, a preliminary SAR was established. All of the peptides (HP1~12) showed significant activity. Among them, PaA-Glu-Glu-Cys-Lys-NH2 (HP12) exhibited the highest activity with about 50 times the potency of phenylacetic acid in the potentiating activity of retinoic acid to induce cell differentiation.
author2 Sheng Chu Kuo
author_facet Sheng Chu Kuo
Yuan Shan Tu
涂源善
author Yuan Shan Tu
涂源善
spellingShingle Yuan Shan Tu
涂源善
Synthesis of Hemoregulatory Peptide(HP) Analogues
author_sort Yuan Shan Tu
title Synthesis of Hemoregulatory Peptide(HP) Analogues
title_short Synthesis of Hemoregulatory Peptide(HP) Analogues
title_full Synthesis of Hemoregulatory Peptide(HP) Analogues
title_fullStr Synthesis of Hemoregulatory Peptide(HP) Analogues
title_full_unstemmed Synthesis of Hemoregulatory Peptide(HP) Analogues
title_sort synthesis of hemoregulatory peptide(hp) analogues
publishDate 2000
url http://ndltd.ncl.edu.tw/handle/95656064709529778386
work_keys_str_mv AT yuanshantu synthesisofhemoregulatorypeptidehpanalogues
AT túyuánshàn synthesisofhemoregulatorypeptidehpanalogues
AT yuanshantu héchénghplèiyuánhuàhéwùzuòwèimatzhīyìzhìjìyǐjíxìbāofēnhuàbāngzhùjì
AT túyuánshàn héchénghplèiyuánhuàhéwùzuòwèimatzhīyìzhìjìyǐjíxìbāofēnhuàbāngzhùjì
_version_ 1716849402380812288